Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High‐Density Lipoprotein–Enriched Serum in Rheumatoid Arthritis

Objective Patients with rheumatoid arthritis (RA) have an increased risk of coronary heart disease (CHD). Some RA therapies may modify this risk, but the underlying mechanisms are unclear. The cholesterol efflux capacity of high‐density lipoprotein (HDL) is associated with a reduced CHD risk in non‐...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Arthritis & rheumatology (Hoboken, N.J.) N.J.), 2016-09, Vol.68 (9), p.2099-2105
Hauptverfasser:	Ormseth, Michelle J., Yancey, Patricia G., Solus, Joseph F., Bridges, S. Louis, Curtis, Jeffrey R., Linton, MacRae F., Fazio, Sergio, Davies, Sean S., Roberts, L. Jackson, Vickers, Kasey C., Kon, Valentina, Michael Stein, C., Bingham, Clifton O., Cofield, Stacey S., Furie, Richard, Gregersen, Peter K., Genovese, Mark C., Robinson, William H., Levesque, Marc C., Moreland, Larry W., Nigrovic, Peter A., Shadick, Nancy A., O'Dell, James R., Thiele, Geoffrey M., St.Clair, E. William, Striebich, Christopher C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adalimumab - pharmacology Adalimumab - therapeutic use Antibodies, Monoclonal, Humanized - pharmacology Antibodies, Monoclonal, Humanized - therapeutic use Antirheumatic Agents - pharmacology Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - metabolism Biological Transport - drug effects Blood Sedimentation Cardiovascular disease Cholesterol Cholesterol - metabolism Female Health risk assessment Humans Lipoproteins, HDL - physiology Longitudinal Studies Male Methotrexate - pharmacology Methotrexate - therapeutic use Middle Aged Rheumatoid arthritis Serum
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!